Each dose increase can reset the clock on gastrointestinal adaptation
Retatrutide is the first triple agonist drug to be tested in this way, and it was unclear whether it would be any more effective than currently approved drugs
Provided that these benefits are proved in future trials, retatrutide can become one of the strongest means of managing obesity and change the future of metabolic health
Beyond glycemic effects, GLP-1 medications act on appetite regulation centers in the hypothalamus, promoting satiety and reducing hunger signals
To address this issue, the treatment of irrigation water to remove microbial and chemical pollutants is crucial
Typical site reactions are redness, swelling, itching, pain, and occasionally nodules